Externally used drug for treating condyloma acuminata and genitalia herpes

A technology for genital herpes and condyloma acuminatum, applied in the field of medicine, can solve the problem of high recurrence rate of the disease

Inactive Publication Date: 2008-07-16
BEIJING HOPE HUGE PHARM SCI
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are many drugs for the treatment of genital herpes at present, the recurrence rate of the disease is relatively high, and there is no effective cure.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Embodiment 1 liniment preparation (1000ml)

[0013] Prescription Acyclovir 2g Brucea javanica oil 10g rose essence 10g 70% ethanol

[0014] Measure acyclovir, javanica javanica oil and rose essence according to the prescription, mix them evenly, add an appropriate amount of 70% ethanol, stir well, then adjust the total amount to 1000ml with 70% ethanol, filter, and pack to obtain.

Embodiment 2

[0015] Embodiment 2 ointment preparation (1000g)

[0016] Prescription Acyclovir 10g Brucea javanica oil 50g

[0017] Take a matrix made of 110g of stearic acid, 9g of potassium carbonate, 25g of glyceryl monostearate, 3ml of triethanolamine, 100g of glycerin and 700ml of water, heat it to 70°C, add the above-mentioned two herbs, mix well, and obtain.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine for external application and for curing condyloma acuminatum and herpes progenitalis. The medicine is mixed by oleum fructus bruceae and clovirs antiviral drugs (such as acyclovir, ganciclovir, etc.) by a certain ratio, which are prepared into externally applicable dosage forms, such as liniment, ointment, etc. by a specific process with medicinally acceptable optional bases. The medicine for external application is characterized by low cost, good curative effect, high recovery rate, and low recurrence rate after recovery, as well as convenient use, safety, reliability and small side-effects during the therapeutic process.

Description

technical field [0001] The invention relates to an external medicine for treating condyloma acuminatum and genital herpes and a preparation method thereof, belonging to the technical field of medicine. Background technique [0002] Genital warts, also known as condyloma acuminata, genital warts (genital warts), and venereal warts. In recent years, due to the continuous expansion of the extension of sexually transmitted diseases, this disease is recognized as a sexually transmitted disease, and it is also one of the most common sexually transmitted diseases in modern society. [0003] Condyloma acuminatum is one of the most common sexually transmitted diseases in European and American countries, and its incidence rate is increasing year by year. According to incomplete statistics, in the past 15 years, the incidence of genital warts in the United States has increased by 5 times. Condyloma acuminatum is also one of the most important venereal diseases in our country. In some ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/185A61K45/06A61P31/20A61P15/00A61K31/522
Inventor 王翰斌李玉娟
Owner BEIJING HOPE HUGE PHARM SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products